4.7 Article

Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan

期刊

CLINICAL MICROBIOLOGY AND INFECTION
卷 16, 期 8, 页码 1164-1168

出版社

ELSEVIER SCI LTD
DOI: 10.1111/j.1469-0691.2009.03078.x

关键词

Line probe assay; multidrug resistance; Mycobacterium tuberculosis; pncA; pyrazinamide

资金

  1. Ministry of Health, Labour, and Welfare of Japan [H21-SHINKO-IPPAN-016]
  2. Grant for International Health Research [2IA-105]
  3. Japan Health Sciences Foundation
  4. Grants-in-Aid for Scientific Research [22590411, 22790423] Funding Source: KAKEN

向作者/读者索取更多资源

P>Thirty-six multidrug-resistant (MDR) Mycobacterium tuberculosis isolates collected in Japan were examined for pyrazinamide susceptibility and pyrazinamidase activity, and analysed by pncA sequencing and a hybridization-based line probe assay (LiPA), which was used to detect pncA mutations for the rapid identification of pyrazinamide-resistant isolates. Pyrazinamide resistance was found in 19 (53%) of them. All pyrazinamide-resistant isolates had no pyrazinamidase activity and at least one mutation in pncA. Among the pncA mutations, 11 had not been previously reported. The results of the LiPA were fully consistent with the DNA sequencing results. A majority of MDR M. tuberculosis isolates in Japan were resistant to pyrazinamide.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据